Archana Alankar, MD
Internal Medicine · White Plains, NYNPI 1972692275
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 79.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,830, 3.3 times the $556 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $60.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Johnson & Johnson$482
- Pfizer$273
- Neurocrine Biosciences, Inc.$137
- Novartis$60
- E.r. Squibb & Sons, L.L.C.$42
- plus $118 from 4 others
What the payments were for
- Food & beverage$5,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 47 | $4,266 |
| Johnson & Johnson | 17 | $482 |
| Pfizer | 14 | $273 |
| Neurocrine Biosciences, Inc. | 1 | $137 |
| Novartis | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Merck | 2 | $41 |
| Fisher & Paykel Healthcare Inc | 1 | $27 |
| AbbVie | 1 | $26 |
| Boehringer Ingelheim | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUX-Dx Insertable Cardiac Monitor$1,100
- EMBLEM$526
- GENERAL - THERAPIES$482
- EMBLEM MRI S-ICD$447
- RESONATE$254
- WATCHMAN FLX$155
- INGREZZA$137
- GENERAL TACHY$104
How this compares
$5,378 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 11 | $156 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $151 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in White Plains
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.